Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost-Differential in Treatment of AMR

被引:0
作者
Banga, R. [1 ]
Schinstock, C. [1 ]
Boscoe, A. [4 ]
Hathcock, M. [3 ]
Kremers, W. [3 ]
Stegall, M. [2 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Div Transplantat Surg, Rochester, MN USA
[3] Mayo Clin, Div Biostat, Rochester, MN USA
[4] Alex Pharmaceut, Hlth Outcomes Res, Cheshire, CT USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
3017
引用
收藏
页数:1
相关论文
共 50 条
[41]   A Prospective, Multicenter Collaborative Experience with a Proteasome Inhibitor Based Protocol for Antibody Mediated Rejection (AMR): Results in Early Versus Late AMR. [J].
Woodle, E. S. ;
Wall, G. E. ;
Light, J. ;
Franklin, C. ;
Joseph, J. ;
Rubin, M. ;
Goebel, J. ;
Baran, D. ;
Browne, B. ;
Gill, J. ;
Shapiro, R. ;
Lewis, R. ;
Gabardi, S. ;
Roberti, I. ;
Girnita, A. ;
Alloway, R. R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 :159-159
[42]   Early diagnosis of antibody mediated rejection (AMR) using daily screening Doppler ultrasonography. [J].
Bar-Nathan, N ;
Davidovitz, M ;
Cleper, R ;
Krause, I ;
Konen, O ;
Tovar, O ;
Mor, E .
PEDIATRIC TRANSPLANTATION, 2005, 9 :104-104
[43]   Diagnosis of antibody-mediated rejection (AMR) on lung transplant biopsies: A retrospective single-center case study [J].
Geleff, Silvana ;
Fischer, Gottfried ;
Jaksch, Peter .
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[44]   Acute Antibody-Mediated Rejection (AMR) in Patient with Autoimmune Hepatitis - Treated with Plasma Exchange, IVIG and Rituximab. [J].
Jessen, Katie A. ;
Chen, John W. ;
Bennett, Alice ;
Muller, Kate ;
Rodgers, Alex ;
Coates, Toby ;
Brooke-Smith, Mark ;
Campbell, Kirsty .
LIVER TRANSPLANTATION, 2013, 19 :S224-S224
[45]   HLA DQ ANTIBODIES ARE THE MOST FREQUENT ANTIBODIES ENCOUNTERED IN ANTIBODY-MEDIATED REJECTION (AMR) OF RENAL ALLOGRAFTS. [J].
Al Meshari, Khalid ;
Pall, Abeed ;
Elgamal, Hazera ;
Alzayer, Fadi ;
Al Awwami, Moheeb .
HUMAN IMMUNOLOGY, 2011, 72 :S187-S187
[46]   Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design [J].
Peter W. Nickerson ;
Georg A. Böhmig ;
Steve Chadban ;
Deepali Kumar ;
Roslyn B. Mannon ;
Teun van Gelder ;
James C. Lee ;
Scott Adler ;
Edward Chong ;
Arjang Djamali .
Trials, 23
[47]   Association of Donor-Specific Antibody (DSA) MFI Value and Features of Antibody-Mediated Rejection (AMR) in Renal Allograft Biopsies [J].
Haririan, A. ;
Papadimitriou, J. ;
Drachenberg, C. ;
Klassen, D. ;
Ramos, E. ;
Nogueira, J. ;
Kukuruga, D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 :417-417
[48]   Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design [J].
Nickerson, Peter W. ;
Boehmig, Georg A. ;
Chadban, Steve ;
Kumar, Deepali ;
Mannon, Roslyn B. ;
van Gelder, Teun ;
Lee, James C. ;
Adler, Scott ;
Chong, Edward ;
Djamali, Arjang .
TRIALS, 2022, 23 (01)
[49]   COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS [J].
Ozdemir, B. Handan ;
Ayva, Sebnem ;
Terzi, Aysen ;
Sade, L. Elif ;
Basturk, Bilkay ;
Sezgin, Atilla .
TRANSPLANT INTERNATIONAL, 2019, 32 :213-213
[50]   The Role of Proteasome Inhibition with Bortezomib in the Treatment of Antibody Mediated Rejection (AMR) after Renal Transplantation [J].
Flechner, Stuart M. ;
Fatica, Richard ;
Askar, Medhat ;
Stephany, Brian ;
Poggio, Emilio ;
Koo, Anna ;
Srinivas, Titte .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 :467-467